BARDA and NOWDiagnostics Partner to Develop Rapid COVID-19 Antibody Test for Use Point-of-Care and At-Home

BARDA and NOWDiagnostics Partner to Develop Rapid COVID-19 Antibody Test for Use Point-of-Care and At-Home
Classified in: Health, Business, Covid-19 virus
Subject: LIC

SPRINGDALE, Ark., Aug. 31, 2020 /PRNewswire/ -- NOWDiagnostics, Inc. announced today it is working with BARDA, the Biomedical Advanced Research and Development Authority arm of the U.S. Department of Health and Human Services, to develop a serological test for SARS-CoV-2 antibodies that can be used across a variety of health care settings?from clinics to hospital emergency rooms?and ultimately by consumers for at-home use.

The ADEXUSDx® COVID-19 Test is a rapid serology, self-contained assay that measures the presence of SARS-CoV-2 antibodies to deliver accurate and reliable results in 15 minutes with no buffers, reagents, or additional equipment. The COVID-19 rapid antibody test, using NOWDiagnostics' self-contained ADEXUSDx® platform, requires no additional materials (reagents and buffers), equipment, processing, or refrigeration. No matter where it is conducted, the ADEXUSDx® COVID-19 Test is designed to deliver lab-quality results in 15 minutes detecting the presence of SARS-CoV-2 antibodies in individuals who have been exposed to the virus. This can include those who have been recently or previously infected with COVID-19, regardless of whether they presented with severe, moderate, mild or no symptoms.
The rapid-results ADEXUSDx® COVID-19 Test requires only a fingerstick to obtain 40 ?L of capillary blood, venous whole blood, serum, or plasma and has the potential to be deployed directly in homes and workplaces. Availability of point-of-care (POC) and over-the-counter (OTC) tests would allow individuals to be screened easily and quickly, yielding test results in minutes instead of days. An application for Emergency Use Authorization (EUA) was filed with the Food and Drug Administration (FDA) in May 2020 for moderate complexity use of the ADEXUSDx® COVID-19 Test.
This project has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, Division of Research Innovation and Ventures under Contract No. 75A50120C00156. BARDA's support for this project includes funding of $695,500 of the project costs and technical support required for NOWDiagnostics to request Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for POC and OTC uses of the ADEXUSDx® COVID-19 Test.
The information contained in this press release is provided by NOWDiagnostics, Inc. and does not indicate endorsement by the federal government of the company or its products.
NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its proprietary ADEXUSDx® platform features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results from days to minutes. For more information about NOWDiagnostics, visit (PRNewsfoto/NOWDiagnostics) SOURCE NOWDiagnostics

These press releases may also interest you at 20:45 Terrace Global Inc. ("Terrace Global" or the "Company") is pleased to announce it has filed its interim unaudited financial results for the quarter ended June 30, 2020. The interim unaudited financial statements and management discussion and...

at 20:43 Genworth Financial, Inc. and China Oceanwide Holdings Group Co. Ltd (Oceanwide) today provided an update on the status of their pending transaction.
As part of the 15th waiver and agreement, which extended the merger agreement to no later than...

at 20:40 Bluma Wellness Inc. (the "Company" or "Bluma Wellness") today provides selected highlights of its financial information for the second quarter of 2020, in conjunction with the release of the Company's unaudited consolidated interim financial...

at 20:37 Choyce Peterson, Inc. (, a commercial real estate brokerage firm which has a specialization in representing tenants, announced the release of the 21st semi-annual version of its Silhouette Study. The full-size poster tracks...

at 20:30 Netskope, the leading security private cloud, today announced the expansion of the Netskope NewEdge network with three new data centers in India. Serving millions of enterprise users around the world and capable of scaling to hundreds of millions,...

at 20:25 Amarillo Gold Corporation (Amarillo or...

News published on 31 august 2020 at 14:22 and distributed by:
imageRead more at: ' + document.location.href, copytext = selection + pagelink, newdiv = document.createElement('div'); = 'absolute'; = '-99999px'; document.body.appendChild(newdiv); newdiv.innerHTML = copytext; selection.selectAllChildren(newdiv); window.setTimeout(function () { document.body.removeChild(newdiv); }, 100);
document.addEventListener('copy', addLink);